Glaucoma is an eye disease in which too high pressure inside the eye causes damage to the optic nerve and a decrease in vision. Unfortunately , sight lost due to Glaucoma cannot be recovered. Today there is important news on the treatment of Glaucoma. The aim of the therapy remains to lower eye pressure and thus avoid further worsening of vision. Here are the most relevant treatments and news.
Eye drops are usually the first therapy when the diagnosis of Glaucoma is made. They work by lowering eye pressure by one of these mechanisms:
Eye drops are the simplest therapy to stop the disease, however in some cases side effects such as burning, tearing, redness of the eyes or changes in blood pressure and/or asthma attacks and coughing limit their use.



In the presence of advanced glaucoma, however, a real surgical operation is necessary where a completely new and alternative outflow route is created to the physiological ones that no longer work. This can be achieved by creating a fistula as in Trabeculectomy or by inserting draining implants such as Ex-Press or Ahmed’s Valve. The good result of these interventions requires follow-up at close intervals to prevent the scarring produced by our body from neutralizing the effect of the intervention.
Today Glaucoma has a decidedly better prognosis than a few years ago, and this is thanks to the new eye drops, the new laser treatments and the new devices available today. All this allows us today a much higher success rate in stopping the disease than a few years ago. However, it is important to remember that to overcome this disease, both an early diagnosis and close checks that allow everything to be monitored with the necessary attention are always necessary. We are at your disposal to offer you all the latest news made available by technology as well as all the attention and care that are necessary to overcome this disease, find here all the news on the diagnosis and treatment of Glaucoma as well as the testimonies of operated patients.
News
You might also be interested in the following news on similar topics: